Our study in collaboration with the Regional Cancer Center (RCC) has been presented on KICancer - StratCan. The study will investigate the two difficult-to-diagnose cohorts; CUP (cancer of unknown primary) and SCAN (Suspected cancer based on serious symptoms) in all together 200 patients at Södertälje Hospital. The study begins to recruit patients in the coming weeks. Very exciting days for us at iCellate!
View the press release here.